Baird Maintains Neutral on Gilead Sciences, Maintains $80 Price Target
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Brian Skorney maintains a Neutral rating on Gilead Sciences (NASDAQ:GILD) with a price target of $80.
June 20, 2024 | 5:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Baird analyst Brian Skorney has maintained a Neutral rating on Gilead Sciences with a price target of $80. This suggests that the analyst does not foresee significant short-term movement in the stock price.
The Neutral rating and maintained price target of $80 indicate that the analyst does not expect significant short-term changes in Gilead Sciences' stock price. This suggests a stable outlook without major catalysts for upward or downward movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100